Clinical Trial Update: Bevacizumab for Neovascular Age-related Macular Degeneration [NA]

View source ↗

Summary

This update notes the completion of a clinical trial evaluating bevacizumab for neovascular age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Exudative Age-related Macular Degeneration | NA | Status: COMPLETED